Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Accuray Incorporated
Pfizer and Merck indicate they may take advantage of new FDA decision that will give companies more flexibility to tout clinical trial results of COVID-19 therapeutics granted emergency use authorization.
While artificial intelligence has proven its value in drug discovery, for most companies, the power of their AI systems is only as strong as the data those systems are trained on. However, stakeholders – from individual companies to consortiums and service vendors -- are finding creative approaches to overcome the so-called data problem and strengthen their AI models.
Getting Personal With Avail Medsystems’ Daniel Hawkins Who Has Entrepreneurship In His Blood And Recipes For Businesses And Kitchens
Medtech Insight’s new series Getting Personal features conversations with new and veteran senior executives about their journeys to corporate leadership, their motivations, passions and the peaks and valleys of running a medtech company. Daniel Hawkins, founder and CEO of Avail Medsystems discussed how his company virtually connects health care professionals into the operating suite and allows for real-time collaboration.
China has cleared for sale the world's first inhaled vaccine for COVID-19, as China continues to face challenges to its strict "COVID Zero" policies, including a new extended lockdown in a major city, ahead of the upcoming high-stakes National Congress.
- Medical Devices
- Diagnostic Imaging Equipment & Supplies
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Other Names / Subsidiaries
- TomoTherapy, Inc.